Aktie PAREXEL INTERNATIONAL CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen PAREXEL International Corporation

Aktien

US6994621075

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management
PAREXEL International : Medical Research Stock Performance Review -- Exact Sciences, DexCom, and PAREXEL
PAREXEL International : Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
PAREXEL International : Reports Fourth Quarter and Fiscal Year 2017 Results
PAREXEL International : Announces Date of Fourth Quarter and Fiscal Year 2017 Earnings Release
PAREXEL International : and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
PAREXEL International Corporation : Announces $720 Million Senior Notes Offering by West Street Merger Sub, Inc.
PAREXEL International : Two PAREXEL Executives Named to 2017 PharmaVOICE 100
PAREXEL International : Receives CEO Cancer Gold Standard Re-Accreditation
PAREXEL International : Named to the Forbes America’s Best Employers List for Second Consecutive Year
Brower Piven Commences an Investigation into the Proposed Sale of PAREXEL International Corporation and Encourages Investors to Contact the Firm for Additional Information
PAREXEL INTERNATIONAL CORPORATION Former SEC Attorney Willie Briscoe Investigates Sale to Pamplona Capital Management, LLP
PAREXEL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PAREXEL International Corporation
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion
PAREXEL International : Enters Definitive Agreement to Be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. Aktie
  4. Nachrichten PAREXEL International Corporation
  5. Andere Sprachen